Contact
Please use this form to send email to PR contact of this press release:
Masitinib receives orphan drug status for the treatment of amyotrophic lateral sclerosis in Switzerland
TO:
Please use this form to send email to PR contact of this press release:
Masitinib receives orphan drug status for the treatment of amyotrophic lateral sclerosis in Switzerland
TO: